Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report

Trastuzumab emtansina (T-DM1) is an antibody-drug conjugate directed against the HER2 for the treatment of HER2+ mestastatic breast cancer (MBC), who has previously received trastuzumab plus a taxane. According to the results of the EMILIA trial versus lapatinib plus capecitabine T-DM1 shows an impr...

Full description

Saved in:
Bibliographic Details
Published in:Farmacia Hospitalaria
Main Authors: Patricia Miranda Romero, Roberto Marín Gil
Format: Artigo
Language:Inglês
Published: Sociedad Española de Farmacia Hospitalaria 2015
Subjects:
Medicina
Lapatinib
Breast Cancer
Cost effectiveness
Trastuzumab emtansine
Online Access:https://www.redalyc.org/articulo.oa?id=365961302003
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items